AtriCure, Inc. (ATRC)
NASDAQ: ATRC · Real-Time Price · USD
59.88
-1.37 (-2.24%)
At close: Nov 2, 2026, 4:00 PM EST
59.17
-0.71 (-1.19%)
After-hours: Nov 2, 2026, 5:52 PM EST
AtriCure Revenue
AtriCure had revenue of $153.60M in the quarter ending June 30, 2026, with 12.83% growth. This brings the company's total for the last twelve months to $569.62M, up 13.94% year-over-year. In the year 2025, AtriCure had annual revenue of $534.53M with 14.88% growth. That makes AtriCure the 10,532nd largest company in the world by revenue and 2,217th in the United States.
Revenue (ttm)
$569.62M
Revenue Growth
+13.94%
P/S Ratio
5.35
Revenue / Employee
$421,942
Employees
1,350
Market Cap
3.05B
Revenue by Geography
- United States 435.37M 81.4%
- Europe 61.49M 11.5%
- Asia Pacific 30.72M 5.7%
- Other International 6.94M 1.3%
Fiscal year ended Dec 31, 2025 See the full AtriCure breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 534.53M | 69.22M | 14.88% |
| Dec 31, 2024 | 465.31M | 66.06M | 16.55% |
| Dec 31, 2023 | 399.25M | 68.87M | 20.84% |
| Dec 31, 2022 | 330.38M | 56.05M | 20.43% |
| Dec 31, 2021 | 274.33M | 67.80M | 32.83% |
| Dec 31, 2020 | 206.53M | -24.28M | -10.52% |
| Dec 31, 2019 | 230.81M | 29.18M | 14.47% |
| Dec 31, 2018 | 201.63M | 26.91M | 15.40% |
| Dec 31, 2017 | 174.72M | 19.61M | 12.64% |
| Dec 31, 2016 | 155.11M | 25.35M | 19.54% |
| Dec 31, 2015 | 129.76M | 22.30M | 20.75% |
| Dec 31, 2014 | 107.45M | 25.57M | 31.22% |
| Dec 31, 2013 | 81.89M | 11.64M | 16.57% |
| Dec 31, 2012 | 70.25M | 5.85M | 9.08% |
| Dec 31, 2011 | 64.40M | 5.40M | 9.14% |
| Dec 31, 2010 | 59.01M | 4.47M | 8.20% |
| Dec 31, 2009 | 54.53M | -723.47K | -1.31% |
| Dec 31, 2008 | 55.26M | 6.95M | 14.38% |
| Dec 31, 2007 | 48.31M | 10.07M | 26.32% |
| Dec 31, 2006 | 38.24M | 7.29M | 23.54% |
| Dec 31, 2005 | 30.96M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DENTSPLY SIRONA | 3.64B |
| MiniMed Group | 3.22B |
| Envista Holdings | 2.86B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.61B |
| Stevanato Group | 1.40B |
| Warby Parker | 911.61M |
| Azenta | 613.81M |
ATRC News
- 7 days ago - AtriCure to Participate at Upcoming Investor Conferences - Business Wire
- 12 days ago - AtriCure price target raised to $68 from $52 at Citizens - TheFly
- 20 days ago - AtriCure to Announce Third Quarter 2026 Financial Results - Business Wire
- 21 days ago - AtriCure price target raised to $63 from $55 at BTIG - TheFly
- 4 weeks ago - AtriCure downgraded to Hold from Buy at Freedom Capital - TheFly
- 7 weeks ago - AtriCure Transcript: Wells Fargo 21st Annual Healthcare Conference - Transcripts
- 2 months ago - AtriCure price target raised to $60 from $50 at Piper Sandler - TheFly
- 2 months ago - AtriCure to Participate in the 2026 Wells Fargo Health Care Conference - Business Wire